Formation of toxic oligomeric α-synuclein species in living cells

PLoS ONE

Volumn 3, Issue 4, 2008, Pages

  Outeiro, Tiago Fleming ^a,b   Putcha, Preeti ^a   Tetzlaff, Julie E ^a   Spoelgen, Robert ^a   Koker, Mirjam ^a   Carvalho, Filipe ^a   Hyman, Bradley T ^a   McLean, Pamela J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; HEAT SHOCK PROTEIN 70; MUTANT PROTEIN;

ARTICLE; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; FLUORESCENCE ANALYSIS; GENE MUTATION; GLIOMA CELL; HUMAN; HUMAN CELL; OLIGOMERIZATION; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN STABILITY; PROTEIN SYNTHESIS; REGULATORY MECHANISM; WILD TYPE; ANIMAL; CHEMISTRY; CHO CELL; CRICETULUS; FLUORESCENCE MICROSCOPY; GENETICS; HAMSTER; LEWY BODY; METABOLISM; METHODOLOGY; MUTATION; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; ANIMALS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LEWY BODIES; MICROSCOPY, FLUORESCENCE; MUTATION; PARKINSON DISEASE; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY;

EID: 44849125207     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001867     Document Type: Article

References (31)

1. Lucking CB, Brice A (2000) Alpha-synuclein and Parkinson's disease. Cell Mol Life Sci 57: 1894-1908.
2. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95: 6469-6473.
3. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
4. Kruger R, Kuhn W, Muller T,, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
5. Zarranz JJ, Alegre J, Gomez-Esteban JG, Lezcano E, Ros R, et al. (2004) The new mutation, E46K, of alpha-synuclein causes parkinson and Lewy body dementia. Ann Neurol 55: 164-173.
6. Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, et al. (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem 274: 19509-19512.
7. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, et al. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97: 571-576.
8. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302: 841.
9. Outeiro TF, Lindquist S (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302: 1772-1775.
10. Goedert M (2001) Parkinson's disease and other alpha-synucleinopathies. Clin Chem Lab Med 39: 308-312.
11. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909.
12. Cookson MR (2004) The Biochemistry of Parkinson's Disease. Annu Rev Biochem. 74: 29-52.
13. Lansbury PT Jr., Brice A (2002) Genetics of Parkinson's disease and biochemical studies of implicated gene products. Curr Opin Cell Biol 14: 653-660.
14. El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, et al. (2003) Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. Faseb J 17: 1943-1447.
15. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, et al. (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317: 516-519.
16. McLean PJ, Kawamata H, Hyman BT (2001) Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104: 901-912.
17. Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, et al. (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 22: 110-114.
18. Ding TT, Lee SJ, Rochet JC, Lansbury PT Jr. (2002) Annular alpha-synuclein protofibrils are-produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41: 10209-10217.
19. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, et al. (2002) Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322: 1089-1102.
20. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
21. Hu CD, Chinenov Y, Kerppola TK (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell 9: 789-798.
22. Kerppola TK (2006) Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol 7: 449-456.
23. Remy I, Michnick SW (2006) A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods 3: 977-979.
24. Klucken J, Outeiro TF, Nguyen P, McLean PJ, Hyman BT (2006) Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. Faseb J 20: 2050-2057.
25. Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295: 865-868.
26. Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ (2004) Hsp70 reduces alpha-synuclein aggregation and toxicity. J Biol Chem.
27. Outeiro TF, Klucken J, Strathearn KE, Liu F, Nguyen P, et al. (2006) Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem Biophys Res Commun 351: 631-638.
28. Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, et al. (2000) Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann N Y Acad Sci 920: 42-45.
29. Fink AL (2006) The aggregation and fibrillation of alpha-synnelein. Acc Chem Res 39: 628-634.
30. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, et al. (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27: 9220-9232.
31. Kontopoulos E, Parvin JD, Feany MB (2006) {alpha}-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet 15: 3012-3023.